Pfizer beat third-quarter expectations and raised its 2021 forecast again even as sales of its top product, the COVID-19 vaccine Comirnaty, slipped in the U.S. Soaring international sales of the preventive shots helped pushed total Comirnaty revenue close to $13 billion in the quarter, and the drugmaker said Tuesday that it now expects to book about $36 billion in sales from the vaccine this year
Related posts
-
Marmion Abbey selling part of site to housing developer
Marmion Abbey wants to sell part of its campus in Aurora to a residential home builder. -
‘Watch your step’: Gurnee asks public to help solve mystery of disappearing manhole covers
Gurnee police are asking for the public's help in solving a heavy-duty mystery involving disappearing manhole... -
Round Lake Beach police chief to retire
Round Lake Beach Police Chief Wayne Wilde will be retiring from his post effective April 17,...